AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...
The “smart” pill bottle provides physicians and pharmacists with a solution that ensures patients adhere to medications as ...
Photodynamic inactivation using curcumin shows promise in reducing antibiotic resistance diversity in Staphylococcus aureus, ...
17."At eight years old, I got my period. Obviously concerned about how young I was, my mom took me to the doctor. The doctor ...
Diarrheagenic E. coli (DEC) is a major global cause of diarrheal diseases, with certain strains showing alarming levels of antibiotic resistance.
When managing an irritated cornea, choosing among fortified antibiotics, oral antivirals, anti-inflammatories or combination ...
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
Public health experts worry the FDA workforce will be slashed, impeding the ability of the agency to review new medicines ...
Roorkee have uncovered a crucial regulatory mechanism in Acinetobacter baumannii -- a highly drug-resistant superbug ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
Antimicrobial resistance (AMR) presents a significant challenge to global health, necessitating innovative therapeutic ...
You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback